Therefore, SCAD patients with a high MPO concentration > 300 ng/ml and a high concentration of inflammatory markers and reduced concentration of apoAI and HDL-C in which LpPLA2 was increased are at the risk of ACS and stroke [18–20]. The gene discussed is MPO; the disease is stroke disorder.